期刊文献+

河南省116例首诊艾滋病患者抗病毒治疗免疫学效果评价 被引量:5

The change of CD4^+ T-lymphocyte cell count with anti-virus treatment in 116 newly diagnosed AIDS patients,Henan
原文传递
导出
摘要 目的分析河南省2009年首诊为艾滋病(AIDS)后随即接受抗病毒治疗的患者CD4+T淋巴细胞计数的变化情况。方法收集"河南省艾滋病检测实验室网络数据库"登记的116例河南省2009年首诊为AIDS后当年即接受抗病毒治疗的患者资料,将其按照治疗前CD4+T淋巴细胞数分成3组(<20个/μl,20~99个/μl和100~350个/μl),使用SPSS 14.0软件对患者治疗前、治疗后约2个月及5个月的CD4+T淋巴细胞数进行统计学分析。结果首诊后接受治疗的3组患者在治疗约2个月后CD4+T细胞计数同治疗前比较都有提高[<20个/μl组:(84.93±64.33)个/μlvs(9.39±5.10)个/μl,P=0.000;20~99个/μl组:(178.71±135.34)个/μlvs(46.62±18.71)个/μl,P=0.001;100~350个/μl组:(316.81±128.81)个/μlvs(197.66±67.59)个/μl,P=0.002],但是在治疗5个月后3组患者CD4+T细胞计数同治疗2个月时比较差异均无统计学意义。治疗前CD4+T细胞基线低的组达到的治疗效果较差。结论早发现、早治疗仍应是河南省开展AIDS防治的工作重点,同时应进一步加强首诊患者的随访和管理。 Objective To analyze the change of CD4+ T-lymphocyte cell count with antiretroviral therapy(ART) in newly diagnosed AIDS patients.Methods One hundred and sixteen newly diagnosed AIDS patients were under ART treatment in Henan,2009.We categorized the patients into three groups by CD4+T cell counts before ART,the group with CD4+T cell counts of 100-350 cells/μl,20-99 cells /μl and lower than 20 cells/μl,respectively.The CD4 cell counts were measured again after 2 and 5 months of ART treatment.The analysis of variance(ANOVA) was used to compare the changes of CD4 cell counts for different groups by SPSS 14.0.Results The mean values of CD4 cell count were significantly increased after 2 months of ART treatment for newly diagnosed AIDS patients with prior CD4 counts of 100-350 cells/μl[from(197.66±67.59)/μl to(316.81±128.81)/μl],20-99 cells/μl[from(46.62±18.71)/μl to(178.71±135.34)/μl]and lower than 20 cells/μl[from(9.39±5.10)/μl to(84.93±64.33)/μl],respectively(P〈0.05).However,there was no additional improvement after another 3 months treatment in any of the three groups.ART treatment efficacy was poor in AIDS patients with low CD4 counts before the therapy.Conclusions The early detection and treatment of HIV infection is critical for the efficacy of ART.
出处 《中国病毒病杂志》 CAS 2011年第4期276-278,共3页 Chinese Journal of Viral Diseases
基金 国家"十一五"艾滋病和病毒性肝炎等重大传染病防治科技重大专项(No:2009ZX10001-017)
关键词 首诊艾滋病患者 抗病毒治疗 CD4+T淋巴细胞计数 Newly diagnosed AIDS Antiretroviral treatment CD4+ T-lymphocyte cell count
  • 相关文献

参考文献7

  • 1刘彦春,李杏红,李兴旺,伦文辉,闫会文,葛蒙梁,朱学骏.690例HIV+/AIDS首诊病例的临床特征及与免疫状态和病毒载量相关性研究[J].中华流行病学杂志,2007,28(10):1026-1029. 被引量:9
  • 2Ogbuanu IU,Torres ME,Kettinger L,et al.Epidemiologicalcharacterization of individuals with newly reported HIV infec-tion:South Carolina,2004-2005. American Journal of Public Health . 2009
  • 3Li N,,Wang Z,Sun D,et al.HIV among plasma donors andother high-risk groups in Henan,China. Journal of Acquired Immune Deficiency Syndromes . 2010
  • 4Johansson KA,Robberstad B,Northeim OF.Further benefitsby early start of HIV treatment in low income countries:surviv-al estimates of early versus deferred antiretroviral therapy. AIDS Research and Therapy . 2010
  • 5Kitahata MM,Gange SJ,Abraham AG,et al.Effect of early versus deferred antiretroviral therapy for HIV on survival. The New England Journal of Medicine . 2009
  • 6Gras L,Kesselring AM,Griffin JT,et al.CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. JAIDS Journal of Acquired Immune Deficiency Syndromes . 2007
  • 7Hammer,S.Clinical practice. Management of newly diagnosed HIV infection. The New England Journal of Medicine . 2005

二级参考文献15

  • 1赵晓梅,吕维柏.311例艾滋病并发皮肤粘膜感染分析及中药治疗[J].中国医药学报,1996,11(2):55-56. 被引量:12
  • 2Kovacs J, Massur H. Prophylaxis against to opportunistic infections inpatients with human immunodeficiency virus infection. N Engl J Med,2000,342(19) :1416-1429.
  • 3Wannamethee SG, Sirivichayakul S, Phillips AN, et al. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand. Int J Epidemiol,1998,27(2):289-295.
  • 4Miller V, Mocroft A, Reiss P, et al. Relations among CD4 lymphocyte count nadir antiretroviral therapy, and HIV-1 disease progression: results from the euro AIDS study. Ann Intern Med, 1999,130(7) :570- 577.
  • 5Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-assoclated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis, 2000,30 Suppl 1 : S5-14.
  • 6Dore GJ,Hoy JF, Mallal SA, et al. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort. J Acquit Immune Defic Syndr Hum Retrovirol, 1997,16 (1) :39-43.
  • 7Maartens G,Wood R, O' Keefe E, et al. Independent epidemics of heterosexual and homosexual HIV infection in South Africa- survival differences. Q J Med, 1997,90(7) :449- 454.
  • 8Yazdanpanah Y,Chene G, Losina E, et al. Incidence of primary opportunistic infections in two human immunodeficiency virus infected French clinical cohorts. Int J Epidemiol, 2001,30 (4) : 864-871.
  • 9Jerene D,Endale A,Hailu Y, et al. Predictors of early death in a cohort of ethiopian patients treated with HAART. BMC Infect Dis,2006,6: 136.
  • 10Easterbrook PJ,Yu LM,Goetghebeur E. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS,2000,14(5) :561-571.

共引文献8

同被引文献46

  • 1于兰,豆智慧,曲淑霞,张福杰,文毅,赵燕.HAART药物依从性对CD_4细胞增长率的影响研究[J].中国艾滋病性病,2005,11(4):255-257. 被引量:15
  • 2De Clercq E. Anti-HIV drugs [J. Verh K Acad Geneeskd Belg 2007,69(2) 81-104.
  • 3Geretti AM. Antiretroviral resistance[J. J HIV Ther,2006,11(4) 72 73.
  • 4张福杰,王健,王福生,等.国家免费艾滋病抗病毒药物治疗手册.第3版.北京:人民出版社,2012.45.
  • 5Rusconi S. Revisiting the concept of a genetic barrier to resistance [J]. J HIV Ther,2006,11(4) ..81-83.
  • 6张福杰,王健,王福生,等.国家免费艾滋病抗病毒药物治疗手册[M].3版.北京:人民卫生出版社,2012:183-185.
  • 7詹思延.流行病学[M].7版.北京:人民卫生出版社,2012.
  • 8张文彤,董伟.SPSS统计分析高级教程[M].2版.北京:高等教育出版社,2013:365-371.
  • 9Ghate M,Deshpande S, Tripathy S, et al. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: Analysis by stages of immunosuppression represented by CD4 counts [J]. Int J Infect Dis, 2009,13 ( 1 ) : e 1-8.
  • 10Moore DM, Hogg RS, Chan K, et al. Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response [J]. AIDS, 2006,20(3) :371-377.

引证文献5

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部